Citadel Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,500
| Closed | -$178K | – | 15651 |
|
|
2023
Q3 | $178K | Buy |
7,500
+6,000
| +400% | +$113K | ﹤0.01% | 10105 |
|
|
2023
Q2 | $24.3K | Sell |
1,500
-200
| -12% | -$3.31K | ﹤0.01% | 12559 |
|
|
2023
Q1 | $29.6K | Buy |
1,700
+100
| +6% | +$1.8K | ﹤0.01% | 12747 |
|
|
2022
Q4 | $30K | Buy |
+1,600
| New | +$30.8K | ﹤0.01% | 12747 |
|
|
2019
Q2 | – | Sell |
-12,500
| Closed | -$210K | – | 10038 |
|
|
2019
Q1 | $210K | Buy |
+12,500
| New | +$217K | ﹤0.01% | 8147 |
|
|
2018
Q4 | – | Sell |
-10,200
| Closed | -$205K | – | 9937 |
|
|
2018
Q3 | $205K | Buy |
+10,200
| New | +$216K | ﹤0.01% | 8182 |
|
|
2017
Q4 | – | Sell |
-16,600
| Closed | -$261K | – | 8564 |
|
|
2017
Q3 | $261K | Buy |
+16,600
| New | +$268K | ﹤0.01% | 6283 |
|
|
2016
Q4 | – | Sell |
-12,900
| Closed | -$146K | – | 8008 |
|
|
2016
Q3 | $146K | Buy |
+12,900
| New | +$155K | ﹤0.01% | 6490 |
|
|
2016
Q2 | – | Sell |
-17,200
| Closed | -$262K | – | 7561 |
|
|
2016
Q1 | $262K | Buy |
17,200
+9,000
| +110% | +$137K | ﹤0.01% | 5281 |
|
|
2015
Q4 | $132K | Buy |
8,200
+4,200
| +105% | +$61.3K | ﹤0.01% | 6375 |
|
|
2015
Q3 | $50K | Sell |
4,000
-11,200
| -74% | -$154K | ﹤0.01% | 7589 |
|
|
2015
Q2 | $252K | Buy |
15,200
+9,000
| +145% | +$145K | ﹤0.01% | 6006 |
|
|
2015
Q1 | $99K | Sell |
6,200
-1,200
| -16% | -$19.8K | ﹤0.01% | 6847 |
|
|
2014
Q4 | $115K | Buy |
7,400
+600
| +9% | +$8.77K | ﹤0.01% | 6527 |
|
|
2014
Q3 | $94K | Sell |
6,800
-13,700
| -67% | -$208K | ﹤0.01% | 6458 |
|
|
2014
Q2 | $329K | Buy |
20,500
+5,900
| +40% | +$93.3K | ﹤0.01% | 4936 |
|
|
2014
Q1 | $246K | Buy |
14,600
+3,500
| +32% | +$63.5K | ﹤0.01% | 5275 |
|
|
2013
Q4 | $234K | Buy |
11,100
+600
| +6% | +$13.5K | ﹤0.01% | 4860 |
|
|
2013
Q3 | $228K | Sell |
10,500
-5,200
| -33% | -$111K | ﹤0.01% | 4642 |
|
|
2013
Q2 | $294K | Buy |
+15,700
| New | +$286K | ﹤0.01% | 4317 |
|
Other funds holding NXGN
Citadel Advisors's NXGN Position: Q4 2023 in Review
Citadel Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 5,571 shares — an estimated $132K sold.
Citadel Advisors first reported a position in NXGN in Q2 2013 and held it in 38 quarters. The position peaked at $9.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Citadel Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 5,571 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $132K.
- Citadel Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
- Citadel Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $9.8M in Q3 2014.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.